Actively Recruiting
Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment
Led by Peking University People's Hospital · Updated on 2025-09-03
240
Participants Needed
1
Research Sites
247 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study, overweight and obese patients with endometrial cancer treated with fertility- sparing therapy were randomly divided into two groups. The test group was given weight management, while the control group was given routine care. Relevant information such as body morphology and composition, glycolipid metabolism, molecular typing and tumor outcomes of the subjects were collected. By evaluating the tumor outcome and changes in glycolipid metabolism indicators, to confirm the effectiveness and safety of weight management for overweight and obese patients with endometrial cancer and treatd with fertility preservation.
CONDITIONS
Official Title
Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosed with endometrial cancer or atypical hyperplasia
- Immunohistochemical staining and sequencing of pathological tissue performed
- Currently receiving fertility-preserving therapy
- Body mass index (BMI) of 25 kg/m2 or higher
- Provided informed consent to participate
You will not qualify if you...
- Communication barriers preventing participation
- Pregnant women
- Serious medical or surgical complications such as urinary stones, history of renal failure or severe kidney problems, familial dyslipidemia, severe liver disease, chronic metabolic acidosis, history of pancreatitis, severe diabetes, active gallbladder disease, fat digestion disorders, or severe cardiovascular or cerebrovascular diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University People's Hospital
Beijing, China, China, 100044
Actively Recruiting
Research Team
X
Xiaodan Li, Master
CONTACT
Y
Yiqian Chen, Master
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here